M-M-R II (Measles / Mumps / Rubella Virus Vaccine (Live)) - Summary

M-M-R II SUMMARY

M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination against measles (rubeola), mumps and rubella (German measles).

M-M-R II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.

M-M-R II NEWS HIGHLIGHTS

Published Studies Related to M-M-R II (Measles / Mumps / Rubella Vaccine)

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. [2008.03]

The role of message framing in promoting MMR vaccination: evidence of a loss-frame advantage. [2008.01]

Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age. [2007.10]

Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial. [2007.09]

Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. [2007.08]

more>>

Clinical Trials Related to M-M-R II (Measles / Mumps / Rubella Vaccine)

Immunogenicity and Safety of Concomitant Administration of MMRâ„¢ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route [Completed]

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety. [Completed]

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [Active, not recruiting]

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers. [Recruiting]

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine [Completed]

more>>